Multi-Mechanistic and Therapeutic Exploration of Nephroprotective Effect of Traditional Ayurvedic Polyherbal Formulation Using In Silico, In Vitro and In Vivo Approaches.
NEERI KFT
anti-inflammatory activity
antioxidant activity
cisplatin
nephrotoxicity
network pharmacology
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
09 Jan 2023
09 Jan 2023
Historique:
received:
20
11
2022
revised:
13
12
2022
accepted:
16
12
2022
entrez:
21
1
2023
pubmed:
22
1
2023
medline:
22
1
2023
Statut:
epublish
Résumé
Based on traditional therapeutic claims, NEERI KFT (a traditional Ayurvedic polyherbal preparation) has been innovatively developed in recent time on the decades of experience for treating kidney dysfunction. Due to the lack of scientific evidence, the present investigations are needed to support the rationale use of NEERI KFT. Considering the facts, the study investigated the nephroprotective effect of NEERI KFT against kidney dysfunction using in silico, in vitro and in vivo approaches. In this study, phytochemical and network pharmacology studies were performed for the developed formulation to evaluate the molecular mechanism of NEERI KFT in the amelioration of kidney disease. In vitro nephroprotective and antioxidant effect of NEERI KFT was determined on HEK 293 cells against cisplatin-induced cytotoxicity and oxidative stress. In vivo nephroprotective effect of NEERI KFT was determined against cisplatin-induced nephrotoxicity in Wistar rats, via assessing biochemical markers, antioxidant enzymes and inflammatory cytokines such as TNF-α, IL-1β, CASP-3, etc. The results showed that the compounds such as gallic acid, caffeic acid and ferulic acid are the major constituents of NEERI KFT, while network pharmacology analysis indicated a strong interaction between polyphenols and several genes (CASPs, ILs, AGTR1, AKT, ACE2, SOD1, etc.) involved in the pathophysiology of kidney disease. In vivo studies showed a significant (p < 0.05) ameliorative effect on biochemical markers and antioxidant enzymes (SOD, CAT, GSH, etc.), and regulates inflammatory cytokine (TNF-α, IL-1β, CASP-3) expression in kidney tissue. Hence, it can be concluded that NEERI KFT subsequently alleviates renal dysfunction mediated by cisplatin via attenuating oxidative and inflammatory stress, thus preserving the normalcy of kidney function.
Identifiants
pubmed: 36672676
pii: biomedicines11010168
doi: 10.3390/biomedicines11010168
pmc: PMC9855918
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Electrolyte Blood Press. 2014 Dec;12(2):55-65
pubmed: 25606044
J Physiol. 2014 Sep 15;592(18):3953-4
pubmed: 25225258
Biomed Res Int. 2018 Sep 12;2018:1462802
pubmed: 30276200
BMC Complement Altern Med. 2014 Jul 16;14:243
pubmed: 25026962
Food Chem Toxicol. 2017 Dec;110:62-73
pubmed: 29024717
Biomed Pharmacother. 2016 Dec;84:740-746
pubmed: 27710898
Ren Fail. 2012;34(7):901-6
pubmed: 22680615
J Pharm Pharmacol. 2012 Jun;64(6):872-81
pubmed: 22571266
Evid Based Complement Alternat Med. 2021 Dec 31;2021:2847440
pubmed: 35003294
J Ethnopharmacol. 2005 Jan 4;96(1-2):121-5
pubmed: 15588659
Methodist Debakey Cardiovasc J. 2018 Oct-Dec;14(4):305-307
pubmed: 30788019
J Food Biochem. 2022 Apr;46(4):e13852
pubmed: 34250628
Int Sch Res Notices. 2014 Aug 11;2014:984709
pubmed: 27382634
Heliyon. 2019 Mar 28;5(3):e01365
pubmed: 30976670
Interdiscip Toxicol. 2015 Jun;8(2):99-102
pubmed: 27486367
Biomed Res Int. 2014;2014:808302
pubmed: 24949473
Afr Health Sci. 2015 Jun;15(2):598-605
pubmed: 26124809
Biomed Pharmacother. 2017 Sep;93:1083-1097
pubmed: 28738532
Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1173-9
pubmed: 27073199
Pharmacognosy Res. 2017 Oct-Dec;9(4):325-332
pubmed: 29263625
Cell Biochem Biophys. 2015 Mar;71(2):535-41
pubmed: 25343941
J Ethnopharmacol. 2017 Feb 2;197:266-273
pubmed: 27496583
Naunyn Schmiedebergs Arch Pharmacol. 2021 Jan;394(1):1-9
pubmed: 32734364
Int J Mol Sci. 2019 Jun 20;20(12):
pubmed: 31226747
Front Pharmacol. 2019 Feb 05;10:27
pubmed: 30804780
Exp Ther Med. 2021 Jun;21(6):638
pubmed: 33968169
Pharm Biol. 2020 Dec;58(1):184-199
pubmed: 32083987
J Appl Toxicol. 2004 Jan-Feb;24(1):27-35
pubmed: 14745844
Pharmacogn Mag. 2017 Jan-Mar;13(49):25-30
pubmed: 28216879
Environ Toxicol Pharmacol. 2017 Sep;54:105-111
pubmed: 28704751
Asian Pac J Trop Biomed. 2012 Aug;2(8):640-4
pubmed: 23569986
Iran J Basic Med Sci. 2020 Jan;23(1):51-62
pubmed: 32405348
Pharm Biol. 2010 Mar;48(3):290-5
pubmed: 20645815
PLoS One. 2018 Nov 16;13(11):e0207672
pubmed: 30444889
Afr Health Sci. 2020 Sep;20(3):1382-1396
pubmed: 33402987
Evid Based Complement Alternat Med. 2019 Jan 6;2019:7523159
pubmed: 30723516
Nutrients. 2019 Apr 26;11(5):
pubmed: 31035482
Biomed Pharmacother. 2019 Aug;116:108961
pubmed: 31146106
Nat Prod Commun. 2017 Feb;12(2):299-308
pubmed: 30428235
ACS Omega. 2020 Nov 12;5(46):29688-29697
pubmed: 33251404
Biomed Res Int. 2019 Dec 6;2019:3960908
pubmed: 31886208
Oncologist. 2017 May;22(5):609-619
pubmed: 28438887
Molecules. 2014 Dec 02;19(12):20139-56
pubmed: 25474287
Int J Mol Sci. 2019 Jul 29;20(15):
pubmed: 31362427
Medicina (Kaunas). 2019 Apr 15;55(4):
pubmed: 30991760
Anticancer Drugs. 2008 Jun;19(5):495-502
pubmed: 18418216
J Ethnopharmacol. 2012 Mar 27;140(2):424-7
pubmed: 22331031
Cancer Chemother Pharmacol. 2017 Nov;80(5):895-907
pubmed: 28730291
Sci Rep. 2019 Nov 4;9(1):15969
pubmed: 31685914
Nephrol Dial Transplant. 2019 Dec 1;34(Suppl 3):iii2-iii11
pubmed: 31800080
Oxid Med Cell Longev. 2019 May 9;2019:2105607
pubmed: 31210837
Saudi J Biol Sci. 2021 Nov;28(11):6441-6453
pubmed: 34764761
J Ethnopharmacol. 2022 Jan 30;283:114743
pubmed: 34655670